SCHEMBL4940279

SCHEMBL4940279

[CH2]C(O)[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594959 0.75
SCHEMBL1983210 0.72
SCHEMBL28290259 0.72
SCHEMBL10549230 0.72
SCHEMBL9512718 0.69
SCHEMBL9331171 0.69 ALDH1A1 (0.35)
SCHEMBL3903356 0.69
SCHEMBL497801 0.69
SCHEMBL27275821 0.69
SCHEMBL27266101 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773346-A1 PHARMACEUTICAL COMPOSITIONS OF HYDROPHOBIC CAMPTOTHECIN DERIVATIVES Taiwan Liposome Company, Ltd. (TW) 2014-09-10 EP claimed
WO-2013067449-A1 PHARMACEUTICAL COMPOSITIONS OF HYDROPHOBIC CAMPTOTHECIN DERIVATIVES TAIWAN LIPOSOME COMPANY, LTD. (TW) 2013-05-10 WO claimed
WO-2012134446-A1 EPIANDROSTERONE AND/OR ANDROSTERONE DERIVATIVES AND METHOD OF USE THEREOF SUTTER WEST BAY HOSPITALS doing business as CALIFORNIA PACIFIC MEDICAL CENTER (US) 2012-10-04 WO claimed
EP-1951231-A2 CAMPTOTHECIN DERIVATIVES AS CHEMORADIOSENSITIZING AGENTS California Pacific Medical Center (US) 2008-08-06 EP claimed
WO-2007095389-A2 TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH CAMPTOTHECINE N-OXIDE AND ANALOGS NOVACEA, INC. (US) 2007-08-23 WO claimed
WO-2007048002-A2 CAMPTOTHECIN DERIVATIVES AS CHEMORADIOSENSITIZING AGENTS CALIFORNIA PACIFIC MEDICAL CENTER (US) 2007-04-26 WO claimed
CN-1249149-C Water resistant, oil resistant composition and its forming product ASAHI GLASS CO LTD (JP) 2006-04-05 CN claimed
EP-1383772-A2 NITROGEN-BASED CAMPTOTHECIN DERIVATIVES California Pacific Medical Center (US) 2004-01-28 EP claimed
WO-2003101998-A1 NITROGEN-BASED HOMO-CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2003-12-11 WO claimed
WO-2003101406-A1 HOMO-CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2003-12-11 WO claimed
EP-1353673-A1 CAMPTOTHECIN DERIVATIVES California Pacific Medical Center (US) 2003-10-22 EP claimed
CN-1408753-A Water resistant, oil resistant composition and its forming product ASAHI GLASS CO LTD (JP) 2003-04-09 CN claimed
WO-2002070525-A2 NITROGEN-BASED CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2002-09-12 WO claimed
WO-2002056885-A1 CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2002-07-25 WO claimed
CN-1247870-A Phosphonic compound UNIV BEIJING CHEMICAL ENG (CN) 2000-03-22 CN claimed
EP-2808324-A1 PYRROLE COMPOUND Kabushiki Kaisha Yakult Honsha (JP) 2014-12-03 EP disclosed
US-20140343017-A1 PYRROLE COMPOUND KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-11-20 US disclosed
CN-1048243-C Alkylation method of triazine derivative NISSAN CHEMICAL IND LTD (JP) 2000-01-12 CN disclosed
CN-1127506-A Method of alkylating triazine derivative NISSAN CHEMICAL IND LTD (JP) 1996-07-24 CN disclosed
US-4565824-A Certain nitratoalkyl ester dihydropyridines having antihypertensive properties BAYER AKTIENGESELLSCHAFT (DE) 1986-01-21 US disclosed